Saturday, February 04, 2006


National HCV Prison Coalition - Hepatitis C Awareness Project (Chronic Hepatitis C)


National HCV Prison Coalition - Hepatitis C Awareness Project
The National Hepatitis C Prison Coalition provides support to prison inmates who are suffering from hepatitis.

Call for Abstracts
HCV in special, difficult to treat populations (e.g. HIV/HCV co-infection, paediatric HCV and HCV in the transplantation setting). There will be a special focus on the expanding problem of HIV/HCV co

Hadley
Wabash 859-525-9300 HCV Independent Distributor Phone Products Carried Remarks Arvin Meritor/Euclid 440-461-4300 HCV Distributor Balkamp (NAPA) 800-538-6272 Horns

Friday, February 03, 2006


Hepatitis C (Chronic Hepatitis C)


Hepatitis C
Title: Hepatitis CCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 9/17/2005

Re:Wheres My Hair
Blink: Hepatitis C Bio, Pics, News and Views from BlinkBits Subject: Re:Wheres My HairAdded by glog on Feb 03, 2006 12:31 pm (GMT -4) Beverly. Well, as long as we are being ladies tonight, I made a jerk off gesture during group tonight. I bet that went over well....... [url=http://hepatitisc.tribe.net/thread/f8e18c6e-6675-4281-9a5d-eae53bc6f4b3#9505b835-535f-4027-bf0c-ed49f80b8527]Read more...[/url] Discover Cheap Flights

A Good AASLD Meeting Summary
This is a terrific overview article regarding the AASLD meeting. Liz Highleyman did a fantastic job of condensing the key aspects and announcements. One of the most interesting updates/corrections of known information is the upward measurement of the number of...

Vertex Progresses with VX-950
Vertex is the racehorse to watch right now. They are progressing quicky on their preliminary good results. While it's not yet time to line up for their treatment, we believe theirs will be first to market of the new approaches...

Wednesday, February 01, 2006


Cirrhosis Of The Liver (Chronic Hepatitis C)


Cirrhosis Of The Liver
Title: Cirrhosis Of The LiverCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/1/2005

Feedster
No Need to Click Here - I'm just claiming my feed at Feedster....

Vertex Progresses with VX-950
Vertex is the racehorse to watch right now. They are progressing quicky on their preliminary good results. While it's not yet time to line up for their treatment, we believe theirs will be first to market of the new approaches...

VIRAL HEPATITIS :: fixen.moderiosites.com :: Viral Hepatitis (Chronic Hepatitis C)


VIRAL HEPATITIS :: fixen.moderiosites.com :: Viral Hepatitis
... viral hepa5titis, viral hepa6itis, viral heaptitis, viral hep0atitis, vi9ral hepatitis, fviral hepatitis, viral hepatitisw, viral hepatitias, ...

Hep C: Hep C - Drug Information from The Anti-Aging Revolution ...
Interferon in the Treatment of Mutant Type Chronic Viral Heaptitis B [Behavior of ... viral heaptitis viral heptaitis viral hepaittis viral hepattiis viral ...

hbv_research
... 23-Oct-2002 Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B; 23-Oct-2002 Hepatitis C ...

Tuesday, January 31, 2006


Schering-Plough Drug Gets Fast Track (Chronic Hepatitis C)


Schering-Plough Drug Gets Fast Track
MSN MoneyCentral - KENILWORTH, N.J. (AP) - Drug maker Schering-Plough Corp. said Monday that regulators granted "fast track" status to its experimental hepatitis C treatment. The Food and Drug Administration gives the fast track label -- which sometimes helps speed the

New Approach To 'break The Code' For Liver Cancer Test
Medical News Today - Scientists at Birmingham University, UK, are using cutting edge technologies to move closer to a blood test that will improve early diagnosis of liver cancer in high risk groups, according to research published in the British Journal of Cancer* today

Inovio Biomedical to Develop Vaccine for Hepatitis C in Partnership
Genetic Engineering News - Inovio Biomedical Corporation (AMEX:INO), a late stage developer of cancer and other therapies using electroporation to deliver drugs and nucleic acids, announced today that it has signed an agreement with Swedish-based Tripep AB (The Stockholm

Defendant calls it self-defense
Fort Wayne Journal Gazette - AUBURN An Auburn man on trial for murder killed in self-defense, his attorney said Monday during the start of his trial. David Dean Barany, 30, of the 300 block of North Baxter Street in Auburn, is charged with the May 27 death of John Mark

Virexx Medical Corp
Stockhouse Canada - Founded with the support of two of Canada's most decorated scientists, Virexx Medical Corp., is an Edmonton, Alberta based biotechnology company focused on the development of novel therapeutic products for the treatment of cancer and chronic viral

Monday, January 30, 2006


Hepatitis B (Chronic Hepatitis C)


Hepatitis B
Title: Hepatitis BCategory: Diseases and ConditionsCreated: 1/26/2001 11:58:00 AMLast Editorial Review: 9/21/2005

Magnetic Resonance Imaging (MRI Scan)
Title: Magnetic Resonance Imaging (MRI Scan)Category: Procedures and TestsCreated: 12/31/1997Last Editorial Review: 8/31/2005

Weight-based Treatment of HCV
Weight-based dosing has always made sense to us. We don't really understand why Roche has not changed their dosing to weight-based. Although the difference is subtle, it is certainly significant according to this study. You must also note, though, that...

Tripep initiates clinical development of ChronVac-C for the ... (Chronic Hepatitis C)


Tripep initiates clinical development of ChronVac-C for the ...
Biotech Intelligence (press release), France - Jan 16, 2006... AMEX:INO; www.inovio.com) regarding clinical development of Tripep's therapeutic vaccine ChronVac-C for the treatment of chronic hepatitis C virus infection. ...

Migenix to start HCV drug trial in Q2
United Press International - Jan 23, 2006... it would begin a Phase 2b viral kinetics clinical trial of its first-in-class oral therapy MX-3253 (celgosivir) in patients with chronic hepatitis C virus (HCV ...

Zacks.com Announces That Vivian Lewis Highlights the Following ...
Business Wire (press release), CA - Jan 17, 2006... began of the AB-rated generic equivalent of Roche's Copegus (R), used in combination with peginterferon alfa-2a to treat adults with chronic hepatitis C virus. ...

Schering-Plough Reports FDA Grants Fast Track Designation to Oral ...
Finanzen.net, Germany - 3 hours ago... investigational oral hepatitis C protease inhibitor (SCH 503034), currently in Phase II clinical development for the treatment of chronic hepatitis C virus (HCV ...

Sunday, January 29, 2006


Tarvacin(TM) Anti-Viral Hepatitis C Clinical Program in Acceleration (Chronic Hepatitis C)


Tarvacin(TM) Anti-Viral Hepatitis C Clinical Program in Acceleration
RxPG - "The initial success of our efforts to accelerate the HCV clinical trial program for Tarvacin Anti-Viral is gratifying in view of Tarvacin's promise as an important new treatment option for a number of viral infections, including chronic hepatitis C